This study aims to determine the validity of a new method to detect COVID-19 by characterising molecules in exhaled air.
Hospital Vall d'Hebron, Spain
Is removing SARS-CoV-2 from the blood sufficient to decrease the severity of critically ill COVID patients? This clinical trial aims to test the efficacy of a new blood filter for the treatment of COVID-19.
Assistance Publique des Hopitaux de Paris, France
Convalescent plasma with anti-SARS-CoV-2 antibodies appears to be a very promising approach in the context of protracted COVID-19 symptoms in patients unable to mount a specific humoral response to SARS-CoV-2.
Hospital Infantil Universitario Niño Jesús, Spain
This clinical trial aims to explore the efficacy of allogeneic mesenchymal cells from umbilical cord tissue in patients with severe COVID-19 lung disease.
Cedars-Sinai Medical Center, Los Angeles
Can sex hormones help men survive COVID-19? This study assesses the safety and efficacy of progesterone for the treatment of COVID-19 in hospitalized men.
Hospital La Paz et al., Spain
Open, randomized, adaptive, phase III clinical trial study to evaluate the efficacy of various pharmacological alternatives in the treatment of severe infection in COVID-19 pediatric patients.
University of Rochester, New York
Clinical trial designed to determine if the vaccine candidate, AZD1222, can prevent symptomatic COVID-19.
Georges-Pompidou European Hospital, France
The STROMA-CoV trial aims to treat patients with severe acute respiratory syndrome due to SARS-CoV-2 by intravenous administration of umbilical cord mesenchymal stromal cells.
The study aims to identify plants based on traditional knowledge that can reduce or eliminate symptoms and the length of illness in non-hospitalised patients with COVID-19.
Hospital Sant Joan de Déu, Spain
Can hydroxychloroquine (HCQ) safely prevent infection and severe complications in pregnant women? This study focues on prevent COVID-19 during pregnancy.
COVACTA study aims to evaluate the efficacy and safety of tocilizumab (TCZ) in hospitalized patients with severe COVID-19 pneumonia.